BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain ...
News | 01 June 2012
LINCOLNSHIRE, Ill., May 31, 2012 (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) announced today that it intends to effect a reverse split of its common stock and class C special stock at a ratio of 1-for-6. The reverse stock split will ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
